/stocks — the workspaceLOADING

MEDP · All filings · Read this filing

What changed 10-K

Item 9A. Controls and Procedures

2024-02-13 compared with 2023-02-14 · 50 added, 1 removed, 159 unchanged (24% of the section changed)

10 unchanged sentences

In the ordinary course of business, we routinely enhance our information systems by either upgrading current systems or implementing new ones.

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the year ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

During the year ended December 31, 2023, we upgraded our accounting enterprise resource planning (“ERP”) platform from an on-premises system to a cloud-based version.

The implementation of that ERP system is expected to, among other things, improve user access security and improve a number of accounting, operational, and reporting processes and activities.

Other than this upgrade, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the year ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Other Information

During the three months ended December 31, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:

Action Date Trading Arrangement Total Shares to be Purchased or Sold Duration/Expiration Date

Rule 10b5-1* Non-Rule 10b5-1**

Medpace Investors, LLC [1] Adopt November 14, 2023 [2]

X Up to 25,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt November 15, 2023 [3]

X Up to 50,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt November 17, 2023 [4]

X Up to 50,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt November 20, 2023 [5]

X Up to 50,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt November 21, 2023 [6]

X Up to 50,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt November 27, 2023 [7]

X Up to 50,000 shares to be sold

Good until cancelled

Medpace Investors, LLC [1] Adopt November 29, 2023 [8]

X Up to 50,000 shares to be sold

Good until cancelled

Burwig , Executive Vice President, Operations

Adopt December 14, 2023 [9]

X Up to 12,400 shares to be sold

The earlier of until cancelled or 180 days from the placement of the limit order

* Intended to satisfy the affirmative defense of Rule 10b5-1(c).

** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).

[1] August J.

Troendle , Chief Executive Officer and Chairman of the Board of the Company , is the sole manager and controlling unit holder of Medpace Investors, LLC (“MPI”) and has sole voting and investment control with respect to the securities held by MPI.

Troendle may be deemed to indirectly beneficially own the securities of the Company held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein .

[2] On November 14, 2023 , MPI placed a limit order to sell up to 25,000 shares that were previously acquired through open market purchases.

[3] On November 15, 2023 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[4] On November 17, 2023 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[5] On November 20, 2023 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[6] On November 21, 2023 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[7] On November 27, 2023 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[8] On November 29, 2023 , MPI placed a limit order to sell up to 50,000 shares that were previously acquired through open market purchases.

[9] On December 14, 2023 , Ms.

Burwig placed a limit order to sell up to 12,400 shares that were previously acquired through an exercise of stock options .

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

97 unchanged sentences

8-K 001-37856 10.1 3/16/22

10.17 Amendment No.

5 dated March 31 , 202 3 to Loan Documents

8-K 001-37856 10.1 3/31/23

19.1 I nsider Trading Comp liance Pol icy

21.1 List of Subsidiaries of Medpace Holdings, Inc.

4 unchanged sentences

32.2 Section 1350 Certification of Chief Financial Officer

97.1 In centive Compensation R ecoupment Policy

101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document *

41 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.